🍽️ l-sorbose

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

Data Contradictions β€” Limits of Certainity

Impacted of l-sorbose On Probiotics

Rank Probiotic Impact

Bacteria Impacted by l-sorbose

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Lachnospiraceae family Increases 👪 Source Study
Lachnospiraceae family Increases 📓 Source Study
Abyssivirga genus Increases 👶 Source Study
Acetatifactor genus Increases 👶 Source Study
Acetitomaculum genus Increases 👶 Source Study
Agathobacter genus Increases 👶 Source Study
Anaerobium genus Increases 👶 Source Study
Anaerobutyricum genus Increases 👶 Source Study
Anaerocolumna genus Increases 👶 Source Study
Anaeromicropila genus Increases 👶 Source Study
Anaeropeptidivorans genus Increases 👶 Source Study
Anaerosacchariphilus genus Increases 👶 Source Study
Anaerosporobacter genus Increases 👶 Source Study
Anaerostipes genus Increases 👶 Source Study
Anaerotaenia genus Increases 👶 Source Study
Anaerotignum genus Increases 👶 Source Study
Bariatricus genus Increases 👶 Source Study
Blautia genus Increases 👶 Source Study
Butyribacter genus Increases 👶 Source Study
Butyrivibrio genus Increases 👶 Source Study
Candidatus Epulonipiscium genus Increases 👶 Source Study
Catenibacillus genus Increases 👶 Source Study
Catonella genus Increases 👶 Source Study
Cellulosilyticum genus Increases 👶 Source Study
Chordicoccus genus Increases 👶 Source Study
Coprococcus genus Increases 👶 Source Study
Cuneatibacter genus Increases 👶 Source Study
Dorea genus Increases 👶 Source Study
Eisenbergiella genus Increases 👶 Source Study
Enterocloster genus Increases 👶 Source Study
Extibacter genus Increases 👶 Source Study
Faecalicatena genus Increases 👶 Source Study
Faecalimonas genus Increases 👶 Source Study
Frisingicoccus genus Increases 👶 Source Study
Fusicatenibacter genus Increases 👶 Source Study
Herbinix genus Increases 👶 Source Study
Hespellia genus Increases 👶 Source Study
Johnsonella genus Increases 👶 Source Study
Kineothrix genus Increases 👶 Source Study
Lachnoanaerobaculum genus Increases 👶 Source Study
Lachnobacterium genus Increases 👶 Source Study
Lachnoclostridium genus Increases 👶 Source Study
Lachnospira genus Increases 👶 Source Study
Lachnotalea genus Increases 👶 Source Study
Lacrimispora genus Increases 👶 Source Study
Lientehia genus Increases 👶 Source Study
Marvinbryantia genus Increases 👶 Source Study
Mediterraneibacter genus Increases 👶 Source Study
Merdimonas genus Increases 👶 Source Study
Mobilitalea genus Increases 👶 Source Study
Moryella genus Increases 👶 Source Study
Muricomes genus Increases 👶 Source Study
Murimonas genus Increases 👶 Source Study
Niameybacter genus Increases 👶 Source Study
Novisyntrophococcus genus Increases 👶 Source Study
Oliverpabstia genus Increases 👶 Source Study
Oribacterium genus Increases 👶 Source Study
Parasporobacterium genus Increases 👶 Source Study
Porcincola genus Increases 👶 Source Study
Pseudobutyrivibrio genus Increases 👶 Source Study
Qiania genus Increases 👶 Source Study
Robinsoniella genus Increases 👶 Source Study
Roseburia genus Increases 👶 Source Study
Schaedlerella genus Increases 👶 Source Study
Sellimonas genus Increases 👶 Source Study
Shuttleworthia genus Increases 👶 Source Study
Simiaoa genus Increases 👶 Source Study
Sporobacterium genus Increases 👶 Source Study
Sporofaciens genus Increases 👶 Source Study
Stomatobaculum genus Increases 👶 Source Study
Syntrophococcus genus Increases 👶 Source Study
Tyzzerella genus Increases 👶 Source Study
Waltera genus Increases 👶 Source Study
Wansuia genus Increases 👶 Source Study
Wujia genus Increases 👶 Source Study
Anaerostipes genus Increases 📓 Source Study
unclassified Anaerostipes no rank Increases ⚗️ Source Study
environmental samples no rank Increases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
Lachnospiraceae incertae sedis no rank Increases 👶 Source Study
unclassified Anaerostipes no rank Increases 👶 Source Study
unclassified Lachnospiraceae no rank Increases 👶 Source Study
unclassified Robinsoniella no rank Increases ⚗️ Source Study
Eubacteriales order Increases 👪 Source Study
Anaerosporobacter mobilis species Increases ⚗️ Source Study
Anaerostipes butyraticus species Increases 👶 Source Study
Anaerostipes caccae species Increases 👶 Source Study
Anaerostipes hadrus species Increases 👶 Source Study
Anaerostipes rhamnosivorans species Increases 👶 Source Study
Anaerostipes sp. 3_2_56FAA species Increases 👶 Source Study
Anaerostipes sp. 5_1_63FAA species Increases 👶 Source Study
Anaerostipes sp. species Increases 👶 Source Study
Anaerostipes sp. 494a species Increases 👶 Source Study
Anaerostipes sp. 992a species Increases 👶 Source Study
Anaerostipes sp. AIP 183.04 species Increases 👶 Source Study
Anaerostipes sp. IE4 species Increases 👶 Source Study

Impact of l-sorbose on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 0.8 0.3 1.67
ADHD 1.1 0.7 0.57
Age-Related Macular Degeneration and Glaucoma 0.4 0.4 0
Allergies 0.4 0.6 -0.5
Allergy to milk products 0.4 -0.4
Alopecia (Hair Loss) 1.2 -1.2
Alzheimer's disease 2 0.4 4
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.4 1.6 -3
Ankylosing spondylitis 0.6 0.8 -0.33
Anorexia Nervosa 1.9 0.3 5.33
Asthma 0.2 0.4 -1
Atherosclerosis 0.2 0.2
Atrial fibrillation 0.6 1.6 -1.67
Autism 2.5 1.9 0.32
benign prostatic hyperplasia 0.2 0.2
Bipolar Disorder 0.4 0.4
Brain Trauma 0.2 0.3 -0.5
Breast Cancer 0.2 -0.2
Carcinoma 0.6 0.6 0
Celiac Disease 1.2 0.6 1
Cerebral Palsy 0.8 0.8
Chronic Fatigue Syndrome 1.5 0.4 2.75
Chronic Kidney Disease 1.2 1.2
Chronic Lyme 0.2 0.2
Chronic Obstructive Pulmonary Disease (COPD) 0.8 0.6 0.33
Chronic Urticaria (Hives) 0.2 0.2
Coagulation / Micro clot triggering bacteria 1.6 1.6
Colorectal Cancer 0.2 0.6 -2
Constipation 0.4 0.6 -0.5
Coronary artery disease 1.4 0.6 1.33
COVID-19 2.5 1.4 0.79
Crohn's Disease 2.8 2 0.4
cystic fibrosis 0.2 0.2
deep vein thrombosis 1.2 1.2
Depression 1.9 2.1 -0.11
Dermatomyositis 0.4 -0.4
Endometriosis 0.5 0.6 -0.2
Eosinophilic Esophagitis 0.3 0.3
Epilepsy 0.6 1.3 -1.17
erectile dysfunction 0.6 -0.6
Fibromyalgia 0.4 1.1 -1.75
Functional constipation / chronic idiopathic constipation 0.6 1 -0.67
gallstone disease (gsd) 0.2 0.8 -3
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.2 0.2
Generalized anxiety disorder 0.2 0.6 -2
Glioblastoma 0.8 0.8
Gout 0.6 0.6
Graves' disease 1.7 0.2 7.5
Halitosis 0.4 0.3 0.33
Hashimoto's thyroiditis 0.2 1.4 -6
Hidradenitis Suppurativa 0.2 0.2
Histamine Issues,Mast Cell Issue, DAO Insufficiency 0.8 0.6 0.33
hypercholesterolemia (High Cholesterol) 0.3 -0.3
hyperglycemia 0.2 0.4 -1
hypersomnia 0.2 0.2
hypertension (High Blood Pressure 1.6 1.6
Hypothyroidism 1.6 1.6
IgA nephropathy (IgAN) 0.4 -0.4
Inflammatory Bowel Disease 1.9 0.2 8.5
Insomnia 0.4 0.4 0
Intelligence 0.8 -0.8
Intracranial aneurysms 0.5 -0.5
Irritable Bowel Syndrome 0.8 1.3 -0.63
Liver Cirrhosis 0.6 1.4 -1.33
Long COVID 3.2 2.1 0.52
Low bone mineral density 1 0.4 1.5
Lung Cancer 1.1 1.1
ME/CFS with IBS 0.2 -0.2
ME/CFS without IBS 0.2 0.2
Metabolic Syndrome 2 1.7 0.18
Mood Disorders 2.4 2.6 -0.08
multiple chemical sensitivity [MCS] 0.2 0.2
Multiple Sclerosis 1.2 0.4 2
Multiple system atrophy (MSA) 0.2 0.2
myasthenia gravis 0.2 -0.2
Neuropathy (all types) 0.9 -0.9
neuropsychiatric disorders (PANDAS, PANS) 0.4 0.4
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 1 0.4 1.5
Obesity 2.1 1 1.1
obsessive-compulsive disorder 1.8 0.4 3.5
Osteoarthritis 0.4 -0.4
Osteoporosis 0.6 0.6
Parkinson's Disease 2.8 0.9 2.11
Polycystic ovary syndrome 0.2 0.6 -2
Postural orthostatic tachycardia syndrome 0.2 0.2 0
Premenstrual dysphoric disorder 0.2 0.4 -1
primary biliary cholangitis 0.6 -0.6
Psoriasis 0.6 0.2 2
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 1.6 2.4 -0.5
Rosacea 0.2 0.2
Schizophrenia 1 1.5 -0.5
scoliosis 0.6 -0.6
sensorineural hearing loss 0.4 0.4
Sjögren syndrome 1 0.4 1.5
Sleep Apnea 1 0.6 0.67
Stress / posttraumatic stress disorder 0.8 0.8 0
Systemic Lupus Erythematosus 1.5 0.6 1.5
Tic Disorder 0.2 0.2
Type 1 Diabetes 0.4 1.2 -2
Type 2 Diabetes 1.2 1.7 -0.42
Ulcerative colitis 1.3 1 0.3
Unhealthy Ageing 0.6 0.2 2

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)